Healthcare Realty Trust Incorporated reported Q4 2025 results with Normalized FFO of $0.40 per share and announced 2026 guidance. The Company completed $682 million in asset sales, reduced Net Debt to Adjusted EBITDA to 5.4x, and established a new $600 million commercial paper program.
Key takeaways
Q4 2025 Normalized FFO was $0.40 per share with Same Store Cash NOI growth of +5.5% and tenant retention of 82.7%.
Full year 2025 asset sales totaled $1.2 billion through 34 transactions at a blended cap rate of 6.7%.
Net Debt to Adjusted EBITDA improved to 5.4x as of December 31, 2025, down from 6.1x at prior year end.
The Company introduced 2026 guidance with Normalized FFO per share range of $1.58 to $1.64.
A new commercial paper program was established allowing issuance of up to $600 million of short-term, unsecured notes.
Board declared a quarterly dividend of $0.24 per share payable March 11, 2026 to shareholders of record February 24, 2026.